Skip to main content
Article
Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)
Articles, Abstracts, and Reports
  • Katherine R. Tuttle, Providence St. Joseph Health
  • Mark Lakshmanan
  • Brian L. Rayner
  • Robert S. Busch
  • Alan G. Zimmermann
  • Brad Woodward
  • Fady T. Botros
Document Type
Abstract
Publication Date
7-1-2018
Clinical Institute
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Nephrology
Comments

General poster session at the European Association for the Study of Diabetes 2018, Berlin, Germany

Citation Information
Katherine R. Tuttle, Mark Lakshmanan, Brian L. Rayner, Robert S. Busch, et al.. "Lesser eGFR Decline with Dulaglutide Regardless of Weight Changes in People with Type 2 Diabetes and Moderate to Severe Chronic Kidney Disease (AWARD-7)" (2018)
Available at: http://works.bepress.com/katherine-tuttle/334/